Stage III Ovarian Cancer AJCC v6 and v7 Active Not Recruiting Phase 1 Trials for Irinotecan (DB00762)

IndicationStatusPhase
DBCOND0093245 (Stage III Ovarian Cancer AJCC v6 and v7)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00576654Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by SurgeryTreatment